ACM
CHRS icon

Aquatic Capital Management’s Coherus Oncology CHRS Stock Holding History

Aquatic Capital Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,200
Closed -$16K – 1217
2022
Q2 		$16K Sell
2,200
-900
-29% -$7.83K 0.01% 879
2022
Q1 		$40K Buy
+3,100
New +$39.4K 0.06% 328

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Aquatic Capital Management's CHRS Position: Q3 2022 in Review

Aquatic Capital Management sold out of Coherus Oncology (CHRS) in Q3 2022, closing a stake of 2,200 shares — an estimated $16K sold.

Aquatic Capital Management first reported a position in CHRS in Q1 2022 and held it in 2 quarters. The position peaked at $40K in Q1 2022. 174 funds tracked by Wall St. Rank hold CHRS as of Q3 2022.

  • Aquatic Capital Management reported no remaining Coherus Oncology position as of Q3 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 2,200 Coherus Oncology shares in Q3 2022, an estimated $16K.
  • Aquatic Capital Management first reported a position in Coherus Oncology in Q1 2022 and held it in 2 quarters.
  • Aquatic Capital Management's Coherus Oncology position peaked at $40K in Q1 2022.
  • 174 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2022.

Based on Aquatic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.